Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Dorigo

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Anti-Cancer Agents in Medicinal Chemistry|February 2, 2012
MMPs in ovarian cancer as therapeutic targetsAmer Karam, Oliver Dorigo
Gynecologic Oncology|February 2, 2012
Treatment outcomes in a large cohort of patients with invasive Extramammary Paget's diseaseAmer Karam, Oliver Dorigo
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2022
Monocytes: A Promising New TRAIL in Ovarian Cancer Cell TherapyStephanie Chow, Oliver Dorigo
Cancer Prevention Research (Philadelphia, Pa.)|September 7, 2011
Personalizing CA125 levels for ovarian cancer screeningOliver Dorigo, Jonathan S Berek
Current Opinion in Obstetrics & Gynecology|December 30, 2021
Cell-based immunotherapies in gynecologic cancersSusan M Lang, Oliver Dorigo
Gynecologic Oncology Reports|May 20, 2021
Long-term efficacy of megestrol acetate and tamoxifen in a recurrent adult granulosa cell tumor of the ovaryAshley S Moon, Oliver Dorigo
Obstetrics and Gynecology|January 14, 2014
Anti-N-methyl-aspartate receptor encephalitis in identical twin sisters: role for oophorectomySalome Masghati, Mana Nosratian, Oliver Dorigo
British Journal of Cancer|June 24, 2022
Macrophage-derived CCL23 upregulates expression of T-cell exhaustion markers in ovarian cancerKalika Kamat, Venkatesh Krishnan, Oliver Dorigo
Vaccines|November 10, 2020
Development of Therapeutic Vaccines for Ovarian CancerStephanie Chow, Jonathan S Berek, Oliver Dorigo
Current Problems in Cancer|February 8, 2017
Immunotherapy in ovarian cancerVenkatesh Krishnan, Jonathan S Berek, Oliver Dorigo
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Anti-Cancer Agents in Medicinal Chemistry|February 2, 2012
MMPs in ovarian cancer as therapeutic targetsAmer Karam, Oliver Dorigo
Gynecologic Oncology|February 2, 2012
Treatment outcomes in a large cohort of patients with invasive Extramammary Paget's diseaseAmer Karam, Oliver Dorigo
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2022
Monocytes: A Promising New TRAIL in Ovarian Cancer Cell TherapyStephanie Chow, Oliver Dorigo
Cancer Prevention Research (Philadelphia, Pa.)|September 7, 2011
Personalizing CA125 levels for ovarian cancer screeningOliver Dorigo, Jonathan S Berek
Current Opinion in Obstetrics & Gynecology|December 30, 2021
Cell-based immunotherapies in gynecologic cancersSusan M Lang, Oliver Dorigo
Gynecologic Oncology Reports|May 20, 2021
Long-term efficacy of megestrol acetate and tamoxifen in a recurrent adult granulosa cell tumor of the ovaryAshley S Moon, Oliver Dorigo
Obstetrics and Gynecology|January 14, 2014
Anti-N-methyl-aspartate receptor encephalitis in identical twin sisters: role for oophorectomySalome Masghati, Mana Nosratian, Oliver Dorigo
British Journal of Cancer|June 24, 2022
Macrophage-derived CCL23 upregulates expression of T-cell exhaustion markers in ovarian cancerKalika Kamat, Venkatesh Krishnan, Oliver Dorigo
Vaccines|November 10, 2020
Development of Therapeutic Vaccines for Ovarian CancerStephanie Chow, Jonathan S Berek, Oliver Dorigo
Current Problems in Cancer|February 8, 2017
Immunotherapy in ovarian cancerVenkatesh Krishnan, Jonathan S Berek, Oliver Dorigo
Pageof 9